|
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Embolism (1829); Thrombus (2101)
|
Event Date 07/02/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
Journal article: restenosis rates after drug-eluting stent treatment for stenotic small-diameter renal arteries.Title: cardiovascular and interventional radiology year: 2019 ref: https://doi.Org/10.1007/s00270-019-02264-z.Average age, majority,gender.Date of publication.Concomitant medical products: statins, antiplatelet agents, angiotensin-converting enzyme inhibitors (aceis), and angiotensin receptor blockers (arbs).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported in a journal article that 37 patients in a study from june 2004 to may 2017 received drug eluting stents to treat main and segmental renal artery stenosis.Among these stents one resolute integrity rx drug eluting stent was used.The device was successfully implanted.Adverse events experienced included in-stent restenosis, all cause death, renal artery embolization, in situ thrombosis.Both the thrombus and the embolism were successfully treated with intra-arterial thrombolysis with tissue plasminogen activator.It was reported that one death occurred within 30 days, which was not related to the renal artery stent procedure.
|
|
Search Alerts/Recalls
|
|
|